“Use of internet-based social media such as Facebook and Twitter can pose compliance risks for drug companies, experts agree.” — I’ll say this: Any time anyone who is employed by a drug (or device, or biotech) company opens their mouth, it’s a compliance risk. Regulated companies can and should use social media channels to market themselves instead of their products.
I was quoted in a Star Tribune story about Twitter. “Because you can have that constant stream of input I feel compelled to constantly consume it,” said Mauter, who follows 200 Twitterers. “It’s terrible if you have an attention deficit problem.” I do have more, more nuanced opinions on Twitter, but that’s certainly one of ...